Probiotic supplementation may help reduce chemotherapy side effects in breast cancer, finds study Dr. Kamal Kant Kohli15 May 2025 8:15 PM ISTChemotherapy is one of the most popular ways to treat breast cancer. Even though it has proven to be effective. it also has downsides, such as a...
Platform-predicted treatments improve outcomes for platinum-resistant ovarian cancer: Study Dr. Kamal Kant Kohli14 April 2025 8:30 PM ISTResults from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more...
Exercise could reduce breast cancer recurrence, finds ECU study Dr. Kamal Kant Kohli7 April 2025 8:00 PM ISTExercise could potentially reduce the recurrence rate of breast cancer, new research from Edith Cowan University (ECU) has found. ECU PhD student Mr...
AstraZeneca Pharma India gets CDSCO nod to import, distribute lung cancer drug Osimertinib Ruchika Sharma7 April 2025 12:30 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization...
AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer Ruchika Sharma4 April 2025 3:30 PM ISTCambridge: AstraZeneca has announced that the Company's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union...
Pitt study makes new insights into origins of ovarian cancer Dr. Kamal Kant Kohli16 March 2025 7:00 PM ISTResearchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that...
Diabetes drug could help cancer patients make better recovery, suggests study Dr. Kamal Kant Kohli11 March 2025 6:45 AM ISTA common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of...
AstraZeneca Imfinzi based perioperative regimen recommended for approval in EU for resectable non-small cell lung cancer Ruchika Sharma4 March 2025 10:15 AM ISTAstraZeneca has announced that Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for...
Blood test could guide use of celecoxib to reduce risk of colon cancer recurrence: Study Dr. Kamal Kant Kohli5 Feb 2025 8:45 PM ISTA data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that...
Cancer drugs linked to severe chronic peripheral nerve pain for 4 in every 10 patients in new research Dr. Kamal Kant Kohli29 Jan 2025 6:00 AM ISTWorldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these...
Green tea-based adhesive films show promise as novel treatment for oral mucositis, reveals study Dr. Kamal Kant Kohli23 Jan 2025 8:15 PM ISTGreen tea shines as a natural powerhouse of antioxidants, with catechins leading the charge among its polyphenols, which protect cells from oxidative...
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Ruchika Sharma21 Jan 2025 1:30 PM ISTLondon: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy...
